PET-CT Scanner Device Market 2026: Future Development, COVID-19 Impact, Manufacturers, Demands and Revenue
PET-CT Scanner Device |
During a single imaging session, a positron emission
tomography (PET) - computed tomography (CT) scan exposes information on the
structure and function of cells and tissues in the body. In recent years, the
bulk of PET scans have been done using devices that combine PET and CT
scanners. The PET-CT scans together provide pictures that show the anatomic
site of aberrant metabolic activity in the body. The results of the combined
scans have been found to be more accurate than the results of the two scans
taken separately.
According to Coherent Market Insights, The global PET-CT
scanner device market size was valued at US$ 1.9 billion in 2017
and is expected to witness a CAGR of 5.1% over the forecast period (2018 –
2026). PET and CT scans are used to diagnose a variety of ailments, including
cancer, heart disease, and some brain abnormalities. PET scanners detect
metabolic activity, while CT scanners reveal anatomical details. The danger of
improper superimposition of different images is decreased, and the hybrid
PET-CT procedure makes the scanning process easier for the patient. PET-CT
scanner hybrids combine the advantages of two well-established imaging
modalities to aid in accurate illness diagnosis, localization, and monitoring.
Furthermore, PET-CT scanners can record pictures in a very short amount of time
(less than a minute).
The rise in incidence of chronic diseases throughout the
world, rising need for effective diagnostic systems, and greater Medicare
coverage for PET-CT scanning are all driving the growth of the PET-CT scanner
equipment market. Furthermore, the increased use of PET-CT for cancer
detection, the introduction of novel technologies, and company expenditures in
R&D are all contributing to the market's growth. However, the market is
projected to be hampered by short shelf life and insufficient supply of
radiopharmaceuticals. Improvements in healthcare infrastructure in emerging
countries, on the other hand, promise profitable market development.
Impact of COVID-19
Pandemic on PET-CT Scanner Device Market
PET imaging allows researchers to track COVID-19's key
pathophysiological changes at the molecular level, providing crucial
information for the disease's subsequent diagnosis, assessment, and therapy.
The most widely employed PET imaging agent in COVID-19 patients is F-labeled
fluorodeoxyglucose (18F-FDG), a radiolabeled glucose analogue, and the
integrated PET/CT system may be used to evaluate the functional and structural
alterations of COVID-19 at the same time. The employment of devices in the
diagnosis and assessment of the COVID-19 aided the growth of the PET-CT
scanning devices market.
COVID-19 has had a rather beneficial influence on the PET-CT
Scanner Device market. The increased use of PET-CT scan devices
in the diagnosis, assessment, and therapy of COVID-19 was linked to this.
Furthermore, cancer patients who get radiation therapy have a higher chance of
developing a more serious condition. The demand for PET CT scanner equipment is
expected to increase as people with cancer become more concerned about the
consequences of COVID-19, which has slowed the market's growth.
Comments
Post a Comment